


Amphilix
Biotechnology Research • Bettingen, Basel, Switzerland • 1-10 Employees
Company overview
| Headquarters | Girenhaldenweg 6, Bettingen, 4126, CH |
| Keywords | Drug Discovery, Oncology, Inflammation, Drug Development, Small Molecule Chimera, Radioligand Therapy |
| Founded | 2020 |
| Employees | 1-10 |
Key Contact at Amphilix
Kevin Mcallister
Founder & Chairman
Amphilix Email Formats
Amphilix uses 1 email format. The most common is {last name} (e.g., doe@amphilix.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{last name} | doe@amphilix.com | 100% |
About Amphilix
Amphilix AG is a Basel, Switzerland based biotech making bifunctional molecules to treat complex diseases using a proprietary linker platform. The linkers employ sophisticated 3D elements which allows the optimization of physicochemical and pharmacokinetic properties. Our lead project is a new First-in-Class targeted radioligand therapy for cancer for which we have teamed up with the Center of Radiopharmaceutical Sciences at the Swiss Federal Institute of Technology (ETH Zürich). Amphilix' drug target is highly expressed in cancer cells and in tumor-associated growing blood vessels and we have demonstrated selective uptake of our radioligand AMX-0053 within a mouse tumor model. The choice of target and use of the proprietary linker platform to optimize the radioligands fully differentiates Amphilix' product from those of other companies.
Amphilix revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Amphilix has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Amphilix has never raised funding before.
Frequently asked questions
4.8
40,000 users



